Skip to main content
Fachgebiete
Automobil + Motoren Bauwesen + Immobilien Business IT + Informatik Elektrotechnik + Elektronik Energie + Nachhaltigkeit Finance + Banking Management + Führung Marketing + Vertrieb Maschinenbau + Werkstoffe Versicherung + Risiko
DE
EN
Bücher
Zeitschriften
Themenseiten
Organisationspsychologie Projektmanagement Marketing Smart Manufacturing
Weitere Formate
Podcasts Webinare Technik Webinare Wirtschaft Kongresse Veranstaltungskalender Awards
Jetzt Einzelzugang starten
Zugang für Unternehmen
Referenzkunden
SLX-Digitalkonferenz: Zukunftswerkstatt 2024

Mehr Umsatz mit Top-Kontakten

Am 7. Mai erfahren Sie, wie Vertriebsteams Leadgenerierung, Leadnurturing und Leadstrategien effizient steuern können.
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
Different Shades of Fungal Metabolites: An Overview Kapitel lesen Erstes Kapitel lesen

2017 | OriginalPaper | Buchkapitel

29. Lanostanoids from Fungi as Potential Medicinal Agents

verfasst von : José-Luis Ríos, Isabel Andújar

Erschienen in: Fungal Metabolites

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Lanostanes are a group of tetracyclic triterpenoids derived from lanosterol. They have relevant biological and pharmacological properties, such as cytotoxicity, immunomodulation, and anti-inflammation. Some of them also have interesting effects on metabolism and anti-infectious properties. This review will compile chemical data, biological effects, and mechanisms on the most relevant lanostanoids isolated from fungi, such as those from Ganoderma lucidum, Poria cocos, Laetiporus sulphureus, Inonotus obliquus, Antrodia camphorata, Daedalea dickinsii, and other.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Jetzt informieren
Vorheriges Kapitel Ergot Alkaloids: Chemistry, Biosynthesis, Bioactivity, and Methods of Analysis
Nächstes Kapitel Kombucha Tea: Metabolites
Literatur
1.
Coates RM (1976) Biogenetic-type rearrangements of terpenes. In: Gerz W, Grisebach H, Kirby GW (eds) Progress in the chemistry of organic natural products, vol 33. Springer, Wien, pp 178–183
2.
Giner-Larza EM, Máñez S, Recio MC, Giner RM, Ríos JL (2000) A review on the pharmacology of lanostanes and related tetracyclic triterpenes. In: Mohan RM (ed) Research advances in phytochemistry. Global Research Net Work, Tivandrum (India), pp 65–82
3.
Ríos JL, Recio MC, Máñez S, Giner RM (2000) Natural triterpenoids as anti-inflammatory agents. In: Atta-ur-Rahman S (ed) Studies in natural products chemistry, vol 22, Part C. Elsevier, Amsterdam, pp 93–143
4.
Hiller K (1987) New results on the structure and biological activity of triterpenoids saponins. In: Hostettmann K, Lea PJ (eds) Biologically active natural products. Oxford Science Publisher, Oxford, pp 167–184
5.
Hostettmann K, Hostettman M, Marston A (1991) Saponins. In: Dey PM, Harbone JB (eds) Methods in plant biochemistry. Academic, London, pp 435–471
6.
7.
8.
9.
10.
Connolly JD, Hill RA (1991) Triterpenoids. In: Dey PM, Harbone JB (eds) Methods in plant biochemistry. Academic, London, pp 331–359
11.
Connolly JD, Hill RA, Ngadjui BT (1994) Triterpenoids. Nat Prod Rep 11:91–117CrossRef
12.
Connolly JD, Hill RA, Ngadjui BT (1994) Triterpenoids. Nat Prod Rep 11:476–492CrossRef
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
Hill RA, Connolly JD (2011) Triterpenoids. Nat Prod Rep 28:1087–1117CrossRef
27.
28.
Hill RA, Connolly JD (2013) Triterpenoids. Nat Prod Rep 30:1028–1065CrossRef
29.
30.
Ríos JL, Andújar I, Recio MC, Giner RM (2012) Lanostanoids from fungi: a group of potential anticancer compounds. J Nat Prod 75:2016–2044CrossRef
31.
Popović V, Živković J, Davidović S, Stevanović M, Stojković D (2013) Mycotherapy of cancer: an update on cytotoxic and antitumor activities of mushrooms, bioactive principles and molecular mechanisms of their action. Curr Top Med Chem 13:2791–2806CrossRef
32.
Liu XT, Winkler AL, Schwan WR, Volk TJ, Rott MA, Monte A (2010) Antibacterial compounds from mushrooms I: a lanostane-type triterpene and prenylphenol derivatives from Jahnoporus hirtus and Albatrellus flettii and their activities against Bacillus cereus and Enterococcus faecalis. Planta Med 76:182–185CrossRef
33.
Huang HC, Liaw CC, Yang HL, Hseu YC, Kuo HT, Tsai YC, Chien SC, Amagaya S, Chen YC, Kuo YH (2012) Lanostane triterpenoids and sterols from Antrodia camphorata. Phytochemistry 84:177–183CrossRef
34.
Majid E, Male KB, Tzeng YM, Omamogho JO, Glennon JD, Luong JH (2009) Cyclodextrin-modified capillary electrophoresis for achiral and chiral separation of ergostane and lanostane compounds extracted from the fruiting body of Antrodia camphorata. Electrophoresis 30:1967–1975CrossRef
35.
Yeh CT, Rao YK, Yao CJ, Yeh CF, Li CH, Chuang SE, Luong JH, Lai GM, Tzeng YM (2009) Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells. Cancer Lett 285:73–79CrossRef
36.
Hsu FL, Chou CJ, Chang YC, Chang TT, Lu MK (2006) Promotion of hyphal growth and underlying chemical changes in Antrodia camphorata by host factors from Cinnamomum camphora. Int J Food Microbiol 106:32–38CrossRef
37.
Shen YC, Chou CJ, Wang YH, Chen CF, Chou YC, Lu MK (2004) Anti-inflammatory activity of the extracts from mycelia of Antrodia camphorata cultured with water-soluble fractions from five different Cinnamomum species. FEMS Microbiol Lett 231:137–143
38.
Lu MY, Fan WL, Wang WF, Chen T, Tang YC, Chu FH, Chang TT, Wang SY, Li MY, Chen YH, Lin ZS, Yang KJ, Chen SM, Teng YC, Lin YL, Shaw JF, Wang TF, Li WH (2014) Genomic and transcriptomic analyses of the medicinal fungus Antrodia cinnamomea for its metabolite biosynthesis and sexual development. Proc Natl Acad Sci U S A 111:E4743–E4752CrossRef
39.
Xie LR, Li DY, Wang PL, Hua HM, Wu X, Li ZL (2013) A new 3, 4-seco-lanostane triterpenoid from a marine-derived fungus Ascotricha sp. ZJ-M-5. Yao Xue Xue Bao 48:89–93, PMID:23600147
40.
Leet JE, Huang S, Klohr SE, McBrien KD (1996) Ascosteroside, a new antifungal agent from Ascotricha amphitricha. J Antibiot (Tokyo) 49:553–559CrossRef
41.
Gorman JA, Chang LP, Clark J, Gustavson DR, Lam KS, Mamber SW, Pirnik D, Ricca C, Fernandes PB, O'Sullivan J (1996) Ascosteroside, a new antifungal agent from Ascotricha amphitricha. I. Taxonomy, fermentation and biological activities. J Antibiot (Tokyo) 49:547–552CrossRef
42.
Lai TK, Biswas G, Chatterjee S, Dutta A, Pal C, Banerji J, Bhuvanesh N, Reibenspies JH, Acharya K (2012) Leishmanicidal and anticandidal activity of constituents of Indian edible mushroom Astraeus hygrometricus. Chem Biodivers 9:1517–1524CrossRef
43.
Arpha K, Phosri C, Suwannasai N, Mongkolthanaruk W, Sodngam S (2012) Astraodoric acids A-D: new lanostane triterpenes from edible mushroom Astraeus odoratus and their anti-Mycobacterium tuberculosis H37Ra and cytotoxic activity. J Agric Food Chem 60:9834–9841CrossRef
44.
Stanikunaite R, Radwan MM, Trappe JM, Fronczek F, Ross SA (2008) Lanostane-type triterpenes from the mushroom Astraeus pteridis with antituberculosis activity. J Nat Prod 71:2077–2079CrossRef
45.
Cabrera GM, Vellasco AP, Levy LM, Eberlin MN (2007) Characterisation of fungal lanostane-type triterpene acids by electrospray ionisation mass spectrometry. Phytochem Anal 18:489–495CrossRef
46.
Yoshikawa K, Kouso K, Takahashi J, Matsuda A, Okazoe M, Umeyama A, Arihara S (2005) Cytotoxic constituents of the fruit body of Daedalea dickisii. J Nat Prod 68:911–914CrossRef
47.
Yoshikawa K, Nishimura N, Bando S, Arihara S, Matsumura E, Katayama S (2002) New lanostanoids, elfvingic acids A-H, from the fruit body of Elfvingia applanata. J Nat Prod 65:548–552CrossRef
48.
Feng W, Yang J, Xu X, Liu Q (2010) Quantitative determination of lanostane triterpenes in Fomes officinalis and their fragmentation study by HPLC-ESI. Phytochem Anal 21:531–538CrossRef
49.
Wu X, Yang J, Zhou L, Dong Y (2004) New lanostane-type triterpenes from Fomes officinalis. Chem Pharm Bull (Tokyo) 52:1375–1377CrossRef
50.
Wu X, Yang JS, Yan M (2009) Four new triterpenes from fungus of Fomes officinalis. Chem Pharm Bull (Tokyo) 57:195–197CrossRef
51.
Bhattarai G, Lee YH, Lee NH, Lee IK, Yun BS, Hwang PH, Yi HK (2012) Fomitoside-K from Fomitopsis nigra induces apoptosis of human oral squamous cell carcinomas (YD-10B) via mitochondrial signaling pathway. Biol Pharm Bull 35:1711–1719CrossRef
52.
Liu XT, Winkler AL, Schwan WR, Volk TJ, Rott M, Monte A (2010) Antibacterial compounds from mushrooms II: lanostane triterpenoids and an ergostane steroid with activity against Bacillus cereus isolated from Fomitopsis pinicola. Planta Med 76:464–466CrossRef
53.
Petrova A, Popov S, Gjosheva M, Bankova V (2007) A new triterpenic alcohol from Fomitopsis pinicola. Nat Prod Res 21:401–405CrossRef
54.
Yoshikawa K, Inoue M, Matsumoto Y, Sakakibara C, Miyataka H, Matsumoto H, Arihara S (2005) Lanostane triterpenoids and triterpene glycosides from the fruit body of Fomitopsis pinicola and their inhibitory activity against COX-1 and COX-2. J Nat Prod 68:69–73
55.
Popova M, Trusheva B, Gyosheva M, Tsvetkova I, Bankova V (2009) Antibacterial triterpenes from the threatened wood-decay fungus Fomitopsis rosea. Fitoterapia 80:263–266CrossRef
56.
Quang DN, Arakawa Y, Hashimoto T, Asakawa Y (2005) Lanostane triterpenoids from the inedible mushroom Fomitopsis spraguei. Phytochemistry 66:1656–1661CrossRef
57.
He J, Feng XZ, Lu Y, Zhao B (2001) Three new triterpenoids from Fuscoporia obliqua. J Asian Nat Prod Res 3:55–61CrossRef
58.
Wang F, Liu JK (2008) Highly oxygenated lanostane triterpenoids from the fungus Ganoderma applanatum. Chem Pharm Bull (Tokyo) 56:1035–1037CrossRef
59.
de Silva ED, van der Sar SA, Santha RG, Wijesundera RL, Cole AL, Blunt JW, Munro MH (2006) Lanostane triterpenoids from the Sri Lankan basidiomycete Ganoderma applanatum. J Nat Prod 69:1245–1248CrossRef
60.
Shim SH, Ryu J, Kim JS, Kang SS, Xu Y, Jung SH, Lee YS, Lee S, Shin KH (2004) New lanostane-type triterpenoids from Ganoderma applanatum. J Nat Prod 67:1110–1113CrossRef
61.
El Dine RS, El Halawany AM, Nakamura N, Ma CM, Hattori M (2008) New lanostane triterpene lactones from the Vietnamese mushroom Ganoderma colossum (Fr.) C.F. Baker. Chem Pharm Bull (Tokyo) 56:642–646CrossRef
62.
El Dine RS, El Halawany AM, Ma CM, Hattori M (2008) Anti-HIV-1 protease activity of lanostane triterpenes from the Vietnamese mushroom Ganoderma colossum. J Nat Prod 71:1022–1026CrossRef
63.
González AG, León F, Rivera A, Padrón JI, González-Plata J, Zuluaga JC, Quintana J, Estévez F, Bermejo J (2002) New lanostanoids from the fungus Ganoderma concinna. J Nat Prod 65:417–421CrossRef
64.
Choi S, Nguyen VT, Tae N, Lee S, Ryoo S, Min BS, Lee JH (2014) Anti-inflammatory and heme oxygenase-1 inducing activities of lanostane triterpenes isolated from mushroom Ganoderma lucidum in RAW264.7 cells. Toxicol Appl Pharmacol 280:434–442CrossRef
65.
Liu DZ, Zhu YQ, Li XF, Shan WG, Gao PF (2014) New triterpenoids from the fruiting bodies of Ganoderma lucidum and their bioactivities. Chem Biodivers 11:982–986CrossRef
66.
Tung NT, Cuong TD, Hung TM, Lee JH, Woo MH, Choi JS, Kim J, Ryu SH, Min BS (2013) Inhibitory effect on NO production of triterpenes from the fruiting bodies of Ganoderma lucidum. Bioorg Med Chem Lett 23:1428–1432CrossRef
67.
Fatmawati S, Shimizu K, Kondo R (2010) Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum. Fitoterapia 81:1033–1036CrossRef
68.
Fatmawati S, Shimizu K, Kondo R (2011) Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors. Bioorg Med Chem Lett 21(24):7295–7297CrossRef
69.
Grienke U, Mihály-Bison J, Schuster D, Afonyushkin T, Binder M, Guan SH, Cheng CR, Wolber G, Stuppner H, Guo DA, Bochkov VN, Rollinger JM (2011) Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum. Bioorg Med Chem 19:6779–6791CrossRef
70.
Lee I, Kim J, Ryoo I, Kim Y, Choo S, Yoo I, Min B, Na M, Hattori M, Bae K (2010) Lanostane triterpenes from Ganoderma lucidum suppress the adipogenesis in 3T3-L1 cells through down-regulation of SREBP-1c. Bioorg Med Chem Lett 20:5577–5581CrossRef
71.
Lee I, Kim H, Youn U, Kim J, Min B, Jung H, Na M, Hattori M, Bae K (2010) Effect of lanostane triterpenes from the fruiting bodies of Ganoderma lucidum on adipocyte differentiation in 3T3-L1 cells. Planta Med 76:1558–1563CrossRef
72.
Lee I, Seo J, Kim J, Kim H, Youn U, Lee J, Jung H, Na M, Hattori M, Min B, Bae K (2010) Lanostane triterpenes from the fruiting bodies of Ganoderma lucidum and their inhibitory effects on adipocyte differentiation in 3T3-L1 Cells. J Nat Prod 73:172–176CrossRef
73.
Lee I, Ahn B, Choi J, Hattori M, Min B, Bae K (2011) Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum. Bioorg Med Chem Lett 21:6603–6607CrossRef
74.
Xu JW, Zhao W, Zhong JJ (2010) Biotechnological production and application of ganoderic acids. Appl Microbiol Biotechnol 87:457–466CrossRef
75.
Jiang J, Grieb B, Thyagarajan A, Sliva D (2008) Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-κB signaling. Int J Mol Med 21:577–584
76.
Wang G, Zhao J, Liu J, Huang Y, Zhong JJ, Tang W (2007) Enhancement of IL-2 and IFN-γ expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo. Int Immunopharmacol 7:864–870CrossRef
77.
Akihisa T, Tagata M, Ukiya M, Tokuda H, Suzuki T, Kimura Y (2005) Oxygenated lanostane-type triterpenoids from the fungus Ganoderma lucidum. J Nat Prod 68:559–563CrossRef
78.
Akihisa T, Nakamura Y, Tagata M, Tokuda H, Yasukawa K, Uchiyama E, Suzuki T, Kimura Y (2007) Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum. Chem Biodivers 4:224–231CrossRef
79.
Tang W, Liu JW, Zhao WM, Wei DZ, Zhong JJ (2006) Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci 80:205–211CrossRef
80.
Campos Ziegenbein F, Hanssen HP, König WA (2006) Secondary metabolites from Ganoderma lucidum and Spongiporus leucomallellus. Phytochemistry 67:202–211CrossRef
81.
Luo J, Zhao YY, Li ZB (2002) A new lanostane-type triterpene from the fruiting bodies of Ganoderma lucidum. J Asian Nat Prod Res 4:129–134CrossRef
82.
Min BS, Nakamura N, Miyashiro H, Bae KW, Hattori M (1998) Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull (Tokyo) 46:1607–1612CrossRef
83.
Min BS, Gao JJ, Nakamura N, Hattori M (2000) Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull (Tokyo) 48:1026–1033CrossRef
84.
Min BS, Gao JJ, Hattori M, Lee HK, Kim YH (2001) Anticomplement activity of terpenoids from the spores of Ganoderma lucidum. Planta Med 67:811–814CrossRef
85.
Ma QY, Luo Y, Huang SZ, Guo ZK, Dai HF, Zhao YX (2013) Lanostane triterpenoids with cytotoxic activities from the fruiting bodies of Ganoderma hainanense. J Asian Nat Prod Res 15:1214–1219
86.
Fatmawati S, Kondo R, Shimizu K (2013) Structure-activity relationships of lanostane-type triterpenoids from Ganoderma lingzhi as α-glucosidase inhibitors. Bioorg Med Chem Lett 23:5900–5903CrossRef
87.
Isaka M, Chinthanom P, Kongthong S, Srichomthong K, Choeyklin R (2013) Lanostane triterpenes from cultures of the Basidiomycete Ganoderma orbiforme BCC 22324. Phytochemistry 87:133–139CrossRef
88.
Niu XM, Li SH, Xiao WL, Sun HD, Che CT (2007) Two new lanostanoids from Ganoderma resinaceum. J Asian Nat Prod Res 9:659–664CrossRef
89.
Liu JQ, Wang CF, Li Y, Luo HR, Qiu MH (2012) Isolation and bioactivity evaluation of terpenoids from the medicinal fungus Ganoderma sinense. Planta Med 78:368–376CrossRef
90.
Sato N, Zhang Q, Ma CM, Hattori M (2009) Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense. Chem Pharm Bull (Tokyo) 57:1076–1080CrossRef
91.
Sato N, Ma CM, Komatsu K, Hattori M (2009) Triterpene-farnesyl hydroquinone conjugates from Ganoderma sinense. J Nat Prod 72:958–961CrossRef
92.
Qiao Y, Zhang XM, Qiu MH (2007) Two novel lanostane triterpenoids from Ganoderma sinense. Molecules 12:2038–2046CrossRef
93.
Liu LY, Chen H, Liu C, Wang HQ, Kang J, Li Y, Chen RY (2014) Triterpenoids of Ganoderma theaecolum and their hepatoprotective activities. Fitoterapia 98:254–259CrossRef
94.
Garlaschelli L, Vidari G, Virtuani M, Vita-Finzi P, Mellerio G (1995) The structures of new lanostane triterpenes from the fruiting bodies of Hebeloma senescens. J Nat Prod 58:992–1002CrossRef
95.
Shao HJ, Qing C, Wang F, Zhang YL, Luo DQ, Liu JK (2005) A new cytotoxic lanostane triterpenoid from the basidiomycete Hebeloma versipelle. J Antibiot (Tokyo) 58:828–831CrossRef
96.
Isaka M, Chinthanom P, Sappan M, Chanthaket R, Luangsa-ard JJ, Prabpai S, Kongsaeree P (2011) Lanostane and hopane triterpenes from the entomopathogenic fungus Hypocrella sp. BCC 14524. J Nat Prod 74:2143–2150CrossRef
97.
Ying YM, Zhang LY, Zhang X, Bai HB, Liang DE, Ma LF, Shan WG, Zhan ZJ (2014) Terpenoids with alpha-glucosidase inhibitory activity from the submerged culture of Inonotus obliquus. Phytochemistry 108:171–176CrossRef
98.
Song FQ, Liu Y, Kong XS, Chang W, Song G (2013) Progress on understanding the anticancer mechanisms of medicinal mushroom: Inonotus obliquus. Asian Pac J Cancer Prev 14:1571–1578CrossRef
99.
Zheng W, Miao K, Liu Y, Zhao Y, Zhang M, Pan S, Dai Y (2010) Chemical diversity of biologically active metabolites in the sclerotia of Inonotus obliquus and submerged culture strategies for up-regulating their production. Appl Microbiol Biotechnol 87:1237–1254CrossRef
100.
Zheng W, Zhang M, Zhao Y, Miao K, Pan S, Cao F, Dai Y (2011) Analysis of antioxidant metabolites by solvent extraction from sclerotia of Inonotus obliquus (Chaga). Phytochem Anal 22:95–102CrossRef
101.
Zheng W, Zhao Y, Zheng X, Liu Y, Pan S, Dai Y, Liu F (2011) Production of antioxidant and antitumor metabolites by submerged cultures of Inonotus obliquus cocultured with Phellinus punctatus. Appl Microbiol Biotechnol 89:157–167CrossRef
102.
Handa N, Yamada T, Tanaka R (2010) An unusual lanostane-type triterpenoid, spiroinonotsuoxodiol, and other triterpenoids from Inonotus obliquus. Phytochemistry 71:1774–1779CrossRef
103.
Nomura M, Takahashi T, Uesugi A, Tanaka R, Kobayashi S (2008) Inotodiol, a lanostane triterpenoid, from Inonotus obliquus inhibits cell proliferation through caspase-3-dependent apoptosis. Anticancer Res 28:2691–2696
104.
Taji S, Yamada T, Wada S, Tokuda H, Sakuma K, Tanaka R (2008) Lanostane-type triterpenoids from the sclerotia of Inonotus obliquus possessing anti-tumor promoting activity. Eur J Med Chem 43:2373–2379CrossRef
105.
Nakata T, Yamada T, Taji S, Ohishi H, Wada S, Tokuda H, Sakuma K, Tanaka R (2007) Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus. Bioorg Med Chem 15:257–264CrossRef
106.
León F, Quintana J, Rivera A, Estévez F, Bermejo J (2004) Lanostanoid triterpenes from Laetiporus sulphureus and apoptosis induction on HL-60 human myeloid leukemia cells. J Nat Prod 67:2008–2011CrossRef
107.
Yoshikawa K, Matsumoto K, Mine C, Bando S, Arihara S (2000) Five lanostane triterpenoids and three saponins from the fruit body of Laetiporus versisporus. Chem Pharm Bull (Tokyo) 48:1418–1421
108.
Kim KH, Moon E, Choi SU, Kim SY, Lee KR (2013) Lanostane triterpenoids from the mushroom Naematoloma fasciculare. J Nat Prod 76:845–851CrossRef
109.
Shi XW, Li XJ, Gao JM, Zhang XC (2011) Fasciculols H and I, two lanostane derivatives from Chinese mushroom Naematoloma fasciculare. Chem Biodivers 8:1864–1870CrossRef
110.
Liu HK, Tsai TH, Chang TT, Chou CJ, Lin LC (2009) Lanostane-triterpenoids from the fungus Phellinus gilvus. Phytochemistry 70:558–563CrossRef
111.
Kamo T, Asanoma M, Shibata H, Hirota M (2003) Anti-inflammatory lanostane-type triterpene acids from Piptoporus betulinus. J Nat Prod 66:1104–1106CrossRef
112.
Feng YL, Zhao YY, Ding F, Xi ZH, Tian T, Zhou F, Du X, Chen DQ, Wei F, Cheng XL, Lin RC (2013) Chemical constituents of surface layer of Poria cocos and their pharmacological properties (I). Zhongguo Zhong Yao Za Zhi 38:1098–1102
113.
Kikuchi T, Uchiyama E, Ukiya M, Tabata K, Kimura Y, Suzuki T, Akihisa T (2011) Cytotoxic and apoptosis-inducing activities of triterpene acids from Poria cocos. J Nat Prod 74:137–144CrossRef
114.
Huang YC, Chang WL, Huang SF, Lin CY, Lin HC, Chang TC (2010) Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation. Eur J Pharmacol 648:39–49CrossRef
115.
Akihisa T, Mizushina Y, Ukiya M, Oshikubo M, Kondo S, Kimura Y, Suzuki T, Tai T (2004) Dehydrotrametenonic acid and dehydroeburiconic acid from Poria cocos and their inhibitory effects on eukaryotic DNA polymerase α and β. Biosci Biotechnol Biochem 68:448–450CrossRef
116.
Akihisa T, Nakamura Y, Tokuda H, Uchiyama E, Suzuki T, Kimura Y, Uchikura K, Nishino H (2007) Triterpene acids from Poria cocos and their anti-tumor-promoting effects. J Nat Prod 70:948–953CrossRef
117.
Akihisa T, Uchiyama E, Kikuchi T, Tokuda H, Suzuki T, Kimura Y (2009) Anti-tumor-promoting effects of 25-methoxyporicoic acid A and other triterpene acids from Poria cocos. J Nat Prod 72:1786–1792CrossRef
118.
Zhou L, Zhang Y, Gapter LA, Ling H, Agarwal R, Ng KY (2008) Cytotoxic and anti-oxidant activities of lanostane-type triterpenes isolated from Poria cocos. Chem Pharm Bull (Tokyo) 56:1459–1462CrossRef
119.
Zheng Y, Yang XW (2008) Poriacosones A and B: two new lanostane triterpenoids from Poria cocos. J Asian Nat Prod Res 10:645–651
120.
Zheng Y, Yang XW (2008) Two new lanostane triterpenoids from Poria cocos. J Asian Nat Prod Res 10:323–328CrossRef
121.
Mizushina Y, Akihisa T, Ukiya M, Murakami C, Kuriyama I, Xu X, Yoshida H, Sakaguchi K (2004) A novel DNA topoisomerase inhibitor: dehydroebriconic acid, one of the lanostane-type triterpene acids from Poria cocos. Cancer Sci 95:354–360CrossRef
122.
Ukiya M, Akihisa T, Tokuda H, Hirano M, Oshikubo M, Nobukuni Y, Kimura Y, Tai T, Kondo S, Nishino H (2002) Inhibition of tumor-promoting effects by poricoic acids G and H and other lanostane-type triterpenes and cytotoxic activity of poricoic acids A and G from Poria cocos. J Nat Prod 65:462–465CrossRef
123.
Cuéllar MJ, Giner RM, Recio MC, Just MJ, Máñez S, Ríos JL (1996) Two fungal lanostane derivatives as phospholipase A2 inhibitors. J Nat Prod 59:977–979CrossRef
124.
Cuéllar MJ, Giner RM, Recio MC, Just MJ, Mañez S, Rios JL (1997) Effect of the basidiomycete Poria cocos on experimental dermatitis and other inflammatory conditions. Chem Pharm Bull (Tokyo) 45:492–494CrossRef
125.
Kanokmedhakul S, Kanokmedhakul K, Prajuabsuk T, Soytong K, Kongsaeree P, Suksamrarn A (2003) A bioactive triterpenoid and vulpinic acid derivatives from the mushroom Scleroderma citrinum. Planta Med 269:568–571
126.
Shiono Y, Sugasawa H, Kurihara N, Nazarova M, Murayama T, Takahashi K, Ikeda M (2005) Three lanostane triterpenoids from the fruiting bodies of Stropharia aeruginosa. J Asian Nat Prod Res 7:735–740CrossRef
127.
Shiono Y, Sugawara H, Nazarova M, Murayama T, Takahashi K, Ikeda M (2007) Three lanostane triterpenoids, aeruginosols A, B and C, from the fruiting bodies of Stropharia aeruginosa. J Asian Nat Prod Res 9:531–535CrossRef
128.
Hien BT, le Hoa TP, le Tham X, Quang DN (2013) Cattienoids A-C, three novel steroids from the mushroom Tomophagus cattienensis. Fitoterapia 91:125–127CrossRef
129.
Quang DN, Hashimoto T, Tanaka M, Asakawa Y (2003) Tyromycic acids F and G: two new triterpenoids from the mushroom Tyromyces fissilis. Chem Pharm Bull (Tokyo) 51:1441–1443CrossRef
130.
Quang DN, Hashimoto T, Tanaka M, Takaoka S, Asakawa Y (2004) Tyromycic acids B-E, new lanostane triterpenoids from the mushroom Tyromyces fissilis. J Nat Prod 67:148–151CrossRef
131.
Ríos JL, Francini F, Schinella GR (2015) Natural products for the treatment of type 2 diabetes mellitus. Planta Med 81:975–994CrossRef
132.
Fall CH (2001) Non-industrialised countries and affluence. Br Med Bull 60:33–50CrossRef
133.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350CrossRef
134.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403CrossRef
135.
Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, STOPNIDDM Trail Research Group (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 15:2072–2077CrossRef
136.
DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR (2006) Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368:1096–1105CrossRef
137.
Ulbricht C, Weissner W, Basch E, Giese N, Hammerness P, Rusie-Seamon E, Varghese M, Woods J (2009) Maitake mushroom (Grifola frondosa): systematic review by the natural standard research collaboration. J Soc Integr Oncol 7:66–72
138.
Petrash JM (2004) All in the family: aldose reductase and closely related aldo-keto reductases. Cell Mol Life Sci 61:737–749CrossRef
139.
Várkonyi T, Kempler P (2008) Diabetic neuropathy: new strategies for treatment. Diabetes Obes Metab 10:99–108
140.
Zaid H, Antonescu CN, Randhawa VK, Klip A (2008) Insulin action on glucose transporters through molecular switches, tracks and tethers. Biochem J 413:201–215CrossRef
141.
Scheepers A, Joost HG, Schurmann A (2004) The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. J Parenter Enteral Nutr 28:364–371CrossRef
142.
Birnbaum MJ (2001) Diabetes. Dialogue between muscle and fat. Nature 409:672–673CrossRef
143.
Sato M, Tai T, Nunoura Y, Yajima Y, Kawashima S, Tanaka K (2002) Dehydrotrametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin-dependent diabetes mellitus to insulin. Biol Pharm Bull 25:81–86CrossRef
144.
Wang L, Waltenberger B, Pferschy-Wenzig EM, Blunder M, Liu X, Malainer C, Blazevic T, Schwaiger S, Rollinger JM, Heiss EH, Schuster D, Kopp B, Bauer R, Stuppner H, Dirsch VM, Atanasov AG (2014) Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Biochem Pharmacol 92:73–89CrossRef
145.
Pellicciari R, Costantino G, Fiorucci SJ (2005) Farnesoid X receptor: from structure to potential clinical applications. Med Chem 48:5383–5403CrossRef
146.
Fiorucci S, Rizzo G, Donini A, Distrutti E, Santucci L (2007) Targeting farnesoid X receptor for liver and metabolic disorders. Trends Mol Med 13:298–309CrossRef
147.
Yedgar S, Cohen Y, Shoseyov D (2006) Control of phospholipase A2 activities for the treatment of inflammatory conditions. Biochim Biophys Acta 1761:1373–1382CrossRef
148.
Jain MK, Yu BZ, Rogers JM, Smith AE, Boger ET, Ostrander RL, Rheingold AL (1995) Specific competitive inhibitor of secreted phospholipase A2 from berries of Schinus terebinthifolius. Phytochemistry 39:537–547CrossRef
149.
Li FF, Yuan Y, Liu Y, Wu QQ, Jiao R, Yang Z, Zhou MQ, Tang QZ (2015) Pachymic acid protects H9c2 cardiomyocytes from lipopolysaccharide-induced inflammation and apoptosis by inhibiting the extracellular signal-regulated kinase 1/2 and p38 pathways. Mol Med Rep 12:2807–2813
150.
Yao X, Li G, Xu H, Lü C (2012) Inhibition of the JAK-STAT3 signaling pathway by ganoderic acid A enhances chemosensitivity of HepG2 cells to cisplatin. Planta Med 78:1740–1748CrossRef
151.
Liu DL, Li YJ, Yang DH, Wang CR, Xu J, Yao N, Zhang XQ, Chen ZS, Ye WC, Zhang DM (2015) Ganoderma lucidum derived ganoderenic acid B reverses ABCB1-mediated multidrug resistance in HepG2/ADM cells. Int J Oncol 46:2029–2038
152.
Ling H, Zhou L, Jia X, Gapter LA, Agarwal R, Ng KY (2009) Polyporenic acid C induces caspase-8-mediated apoptosis in human lung cancer A549 cells. Mol Carcinog 48:498–507CrossRef
153.
Kang HM, Lee SK, Shin DS, Lee MY, Han DC, Baek NI, Son KH, Kwon BM (2006) Dehydrotrametenolic acid selectively inhibits the growth of H-ras transformed rat2 cells and induces apoptosis through caspase-3 pathway. Life Sci 78:607–613CrossRef
154.
Ling H, Zhang Y, Ng KY, Chew EH (2011) Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-κB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res Treat 126:609–620CrossRef
155.
Qiao X, Wang Q, Ji S, Huang Y, Liu KD, Zhang ZX, Bo T, Tzeng YM, Guo A, Ye M (2015) Metabolites identification and multi-component pharmacokinetics of ergostane and lanostane triterpenoids in the anticancer mushroom Antrodia cinnamomea. J Pharm Biomed Anal 111:266–276CrossRef
156.
Zhao F, Mai Q, Ma J, Xu M, Wang X, Cui T, Qiu F, Han G (2015) Triterpenoids from Inonotus obliquus and their antitumor activities. Fitoterapia 101:34–40CrossRef
157.
Kikuchi T, Ishii K, Ogihara E, Zhang J, Ukiya M, Tokuda H, Iida T, Tanaka R, Akihisa T (2014) Cytotoxic and apoptosis-inducing activities, and anti-tumor-promoting effects of cyanogenated and oxygenated triterpenes. Chem Biodivers 11:491–504CrossRef
158.
Zhang L, Ravipati AS, Koyyalamudi SR, Jeong SC, Reddy N, Bartlett J, Smith PT, de la Cruz M, Monteiro MC, Melguizo A, Jiménez E, Vicente F (2013) Anti-fungal and anti-bacterial activities of ethanol extracts of selected traditional Chinese medicinal herbs. Asian Pac J Trop Med 6:673–681CrossRef
Metadaten
Titel
Lanostanoids from Fungi as Potential Medicinal Agents
verfasst von
José-Luis Ríos
Isabel Andújar
Copyright-Jahr
2017
Buch
Fungal Metabolites

Print ISBN: 978-3-319-25000-7

Electronic ISBN: 978-3-319-25001-4

Copyright-Jahr: 2017

DOI
https://doi.org/10.1007/978-3-319-25001-4_19